패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Cronos Group Inc. 20 애널리스트 중 3 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Vahan Ajamian	Beacon Securities Limited
Tamy Chen	BMO Capital Markets Equity Research
Lisa Lewandowski	BofA Global Research

Cronos Group 배당금 및 환매

배당금 기준 확인 0/6

주요 정보

최근 배당금 및 환매 업데이트

Recent updates

Cronos Group Is Probably Undervalued As Liquidity Swells

Cronos Group Inc. Announces Lord Jones Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada

Buy Cronos Stock Before It Surges Higher

Cronos Group Inc. Brand Spinach®? Celebrates Summer with New Launches

Cronos Group Inc. Elects Murray Garnick as Director

Cronos Group: An Intriguing Value Opportunity

Forecast breakeven date moved forward to 2025

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

No longer forecast to breakeven

Cronos Group Inc., Annual General Meeting, Jun 20, 2024

Cronos Group Inc. Launches Lord Jones Chocolate Fusions

Cronos Stock: Attractive Now With Cannabis Legalization In Germany

Full year 2023 earnings: EPS and revenues miss analyst expectations

Cronos Group: Flush With Cash And Trading Below Book Value

Forecast to breakeven in 2026

Cronos Group Inc. Announces Launch of Its Highly Anticipated Lord Jones Live Resin Vapes in Two Different Hardware Options

Future Farmco Canada Inc. entered into an agreement to acquire Peace Naturals Project Inc. from Cronos Group Inc. (TSX:CRON) for CAD 23 million.

Future Farmco Canada Inc. entered into an agreement to acquire Peace Naturals Project Inc. from Cronos Group Inc. (TSX:CRON) for CAD 23 million.

Forecast to breakeven in 2025

Third quarter 2023 earnings released: US$0.005 loss per share (vs US$0.098 loss in 3Q 2022)

New major risk - Revenue and earnings growth

Cronos Group Inc. Launches Its Cannabis Brand Lord Jones in the Canadian Adult-Use Cannabis Market

Cronos Group Inc. Unveils Its New THCV Products: Spinach FEELZ™? Full Tilt

Cronos Group Inc. Revises Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Cronos Reportedly Explores Possible Sale After Attracting Takeover Interest

Cronos Group Inc. Announces Executive Changes

Cronos Group Inc. Provides Revenue Guidance for the Full Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Insufficient new directors

Cronos Unveils Its New CBC Product: Spinach FEELZ™ Day Trip Gummies with THC+CBC

Cronos Group Inc Announces Executive Changes

Cronos Group Inc. Announces Final Settlement Agreements with U.S. Securities and Exchange Commission and the Staff of the Ontario Securities Commission

Cronos Group Inc. Announces Executive Changes

Insufficient new directors

Second quarter 2022 earnings: Revenues miss analyst expectations

Cronos Group GAAP EPS of -$0.05 beats by $0.01, revenue of $23.1M misses by $5.25M

Cronos Group: Too Much Cash, Too Soon - Making The Bear Case

Cronos Group: High Hurdles

Cronos Group Inc., Annual General Meeting, Jun 23, 2022

Cronos Group Inc., Annual General Meeting, Jun 23, 2022

Cronos Earnings: Cannabis Stock With 65% Net Cash And 51% Revenue Growth

Cronos Group Late-Filed Q3-2021 Earnings Show Revenues From Synthetic Cannabinoids

Cronos Group Inc. announced delayed amended 10-Q filing

Cronos Group: Still No Reason To Own

Cronos Group Strategic Investor Altria May Be About To Buy The Balance

After Cronos Finally Invests In U.S. Cannabis, Is The Stock A Buy?

Second quarter 2021 earnings released: EPS US$0.15 (vs US$0.31 loss in 2Q 2020)

Executive Officer Puneet Mathur has left the company

Is Cronos Stock Worth Buying? Probably, But Patience Remains A Requirement

Cronos Group stock rises 2.6% with acquisition of 10.5% stake in PharmaCann

Cronos Group: Still Hasn't Launched

First quarter 2021 earnings released: US$0.43 loss per share (vs US$0.22 profit in 1Q 2020)

Cronos Group Q1 Earnings Preview

Cronos: The Most Confusing Cannabis Stock

Kristen Bell’s Happy Dance™ Available Now at Ulta Beauty™

Executive Chairman recently sold US$6.3m worth of stock

Insider recently sold US$61k worth of stock

Full year 2020 earnings released: US$0.20 loss per share (vs US$3.76 profit in FY 2019)

Revenue beats expectations, earnings disappoint

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: US$11.35

New 90-day high: US$9.06

Investor sentiment improved over the past week

Cronos: Sitting On Your Hands Is Not A Winning Strategy

Market bids up stock over the past week

Cronos Group (CRON) Investor Presentation - Slideshow

Cronos Is A Buy With Increasing Revenues

Executive Chairman recently sold US$9.3m worth of stock

Market bids up stock over the past week

New 90-day high: US$6.47

Cronos shares rise 5% on solid Q3 beat; top-line +96% boosted by advancement in Canadian/Israeli market

Cronos: Failure To Launch